| Literature DB >> 34866653 |
Tarek E Khalil1, Hemmat A Elbadawy1, Asmaa A Attia1, Doaa S El-Sayed1.
Abstract
An innovative charge-transfer complex between the Schiff base 2-((2-hydroxybenzylidene) amino)-2-(hydroxymethyl) propane-1,3-diol [SAL-THAM] and the π-acceptor, chloranilic acid (CLA) within the mole ratio (1:1) was synthesized and characterized aiming to investigate its electronic transition spectra in acetonitrile (ACN), methanol (MeOH) and ethanol (EtOH) solutions. Applying Job`s method in the three solvents supported the 1:1 (CLA: SAL-THAM) mole ratio complex formation. The formation of stable CT- complex was shown by the highest values of charge-transfer complex formation constants, KCT, calculated using minimum-maximum absorbance method, with the sequence, acetonitrile > ethanol > methanol DFT study on the synthesized CT complex was applied based on the B3LYP method to evaluate the optimized structure and extract geometrical and reactivity parameters. Based on TD-DFT theory, the electronic properties, 1H and 13C NMR, IR, and UV-Vis spectra of the studied system in different solvents showing good agreement with the experimental studies. MEP map described the possibility of hydrogen bonding and charge transfer in the studied system. Finally, a computational approach for screening the antiviral activity of CT - complex towards SARS-CoV-2 coronavirus protease via molecular docking simulation was conducted and confirmed with molecular dynamic (MD) simulation.Entities:
Keywords: ACN, acetonitrile; CLA, chloranilic acid; CT-complex, charge transfer complex; Charge-transfer complex; Chloranilic; DFT; DFT, density functional theory; DFT/GIAO, density functional theory/ gauge-including atomic orbital; EtOH, ethanol; GC-376, 3C-like protease; HB, hydrogen bonding; HOMO, higher occupied molecular orbital; LUMO, lower unoccupied molecular orbital; MD, molecular dynamic simulation; MEP, molecular electrostatic potential; MeOH, methanol; Molecular docking; Mpro, main protease; NBO, natural bond orbital; NCI, non-covalent interaction; NCI-RDG, non-covalent interaction-reduced density gradient analysis; NRE, nuclear repulsion energy; PCM, polarizable continuum model; PDB, protein data bank; PLpro, paplian-like protease; SARS-CoV-2; SARS-CoV-2, severe acute respiratory syndrome corona-virus 2; Spectroscopic; TD-DFT, time dependent- density functional theory; VDW, van der Waals
Year: 2021 PMID: 34866653 PMCID: PMC8627645 DOI: 10.1016/j.molstruc.2021.132010
Source DB: PubMed Journal: J Mol Struct ISSN: 0022-2860 Impact factor: 3.841
Scheme 12D graphical representation of proposed structure for charge transfer complex [SAL-THAM-CLA]. (I) H-bond complex structure and (II) mixed H-bond with proton transfer complex structure.
Fig. 1KBr disk FT-IR spectra of SAL-THAM and CT complex [SAL-THAM-CLA].
Fig. 2(A) UV- vis absorption spectra of 2 × 10−4 M of the free donor (SAL-THAM), free acceptor (CLA) and CT complex of [SAL-THAM-CLA] in ethanol; (B) Continues variations method (Job's method) at room temperature of the formed CT complex [SAL-THAM-CLA] in methanol, ethanol, and acetonitrile.
Fig. 3Effect of concentration on the formed CT complex [2.0 × 10−4 mol/dm3 CLA with various concentrations of SAL-THAM from 5.00×10−5 to 4.00×10−4 mol/dm3] in methanol, ethanol, and acetonitrile, at room temperature.
Minimum-maximum absorbance data for CT complex formation KCT of [SAL-THAM-CLA] at room temperature using; methanol, ethanol, and acetonitrile solvents.
| Solvent | λmax (nm) | Conc. SAL-THAM (mol/L) | Amin | Amax | A complex | KCT (L/mol) | Average KCT (L/mol) |
|---|---|---|---|---|---|---|---|
| Methanol | 520 | 0.00010 | 0.135 | 0.387 | 0.151 | 677.966 | 1068.65 |
| 0.00015 | 0.159 | 701.754 | |||||
| 0.00020 | 0.1591 | 526.315 | |||||
| 0.00025 | 0.191 | 1142.85 | |||||
| 0.00030 | 0.201 | 1182.79 | |||||
| 0.00035 | 0.213 | 1280.78 | |||||
| Ethanol | 524 | 0.00010 | 0.610 | 0.826 | 0.690 | 5882.35 | 11,103.29 |
| 0.00015 | 0.726 | 7733.33 | |||||
| 0.00020 | 0.783 | 20,116.28 | |||||
| 0.00025 | 0.778 | 14,000 | |||||
| 0.00030 | 0.782 | 13,030.3 | |||||
| 0.00035 | 0.780 | 10,559.01 | |||||
| Acetonitrile | 514 | 0.00010 | 0.072 | 0.192 | 0.102 | 333.333 | 15,136.5 |
| 0.00015 | 0.138 | 8148.148 | |||||
| 0.00020 | 0.171 | 23,571.43 | |||||
| 0.00025 | 0.159 | 10,545.45 | |||||
| 0.00030 | 0.171 | 15,714.29 | |||||
| 0.00035 | 0.18 | 25,714.29 | |||||
| 0.00040 | 0.178 | 18,928.57 |
Fig. 4The optimized (a) CLA (b) SAL-THAM (c) CT complex [SAL-THAM-CLA].
Reactivity parameters of the complex in gas phase with B3LYP/6–311 g (d,p).
| Parameter | Gas | Methanol |
|---|---|---|
| E | −2235.299 | −2235.228 |
| NRE | 2945.693 | 2945.693 |
| D | 3.503 | 3.943 |
| EHOMO | −8.217 | −7.619 |
| ELUMO | −5.251 | −4.844 |
| EGAP | 2.966 | 2.775 |
| I | 8.217 | 7.619 |
| A | 5.251 | 4.844 |
| Μ | −6.734 | −6.232 |
| Η | 1.483 | 1.388 |
| Σ | 0.674 | 0.720 |
| X | 1.565 | 1.573 |
Fig. 5Molecular orbitals with their energy values for the optimized reactants and product in gas phase.
Fig. 6MEP maps of a) CLA b) SAL-THAM and c) CT complex [CLA-SAL-THAM].
Fig. 7RDG isosurface analysis and NCI scatter mapping diagram of the optimized CT complex.
Fig. 82D-interaction scheme of reference ligands complexed with SARS-CoV-2 protease enzyme (a) 6WTT (b) 6XA4 (c) 6XBH (d) 7JRN.
Free binding energy of reference and synthesized inhibitors with different protein receptors.
| Protein ID | Reference inhibitor code | ∆Gref.inhibitor | ∆GCT-complex |
|---|---|---|---|
| 6WTT | K36 | −7.67 | −5.65 |
| 6XA4 | UXS | −9.59 | −8.01 |
| 6XBH | ELL | −9.52 | −3.17 |
| 7JRN | TTT | −8.92 | −4.73 |
Fig. 9Vertical bar representation the comparable free binding energies between the reference ligands and CT-complex (the blue bar in each figure corresponding to a specific reference ligand and the red bar represents binding affinity results of CT-complex with protein receptors).
Fig. 10Biomolecular solvated box grid including the interacting of CT-complex with active amino acids of (a) 6WTT, (b) 6XA4, (c) 6XBH and (d) 7JRN.
Fig. 11MD simulation showing potential energy related to RMSD for CT-complex actively bound to (a) 6WTT, (b) 6XA4, (c) 6XBH and (d) 7JRN, active sites.
Fig. 122D - RMSD map for binding of CT-complex with 6WTT (a), 6XA4 (b), 6 × 4BH (c) and 7JRN (d); RMSD scanning range varies from 0.8Å-3.6 (white code area color corresponding to RMSD 〈 1.5 and black code colored area is corresponding to RMSD 〉 1.5).